ScholarIQanswers from OpenAlex
HIV/AIDS drug development and treatment
TopicLeading institutions, researchers & key papers
HIV/AIDS drug development and treatment is a topic indexed in ScholarIQ from OpenAlex.
What is known about HIV/AIDS drug development and treatment?
ScholarIQrecord summary
This cluster of papers focuses on the efficacy and safety of antiretroviral therapy for HIV infection, including the development of drug resistance, the use of integrase inhibitors and reverse transcriptase inhibitors, and the adverse effects such as hepatotoxicity and renal toxicity. It also explores the use of nucleoside analogues for treating viral diseases.
How many works does HIV/AIDS drug development and treatment have?
ScholarIQindexed works
HIV/AIDS drug development and treatment has 274 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for HIV/AIDS drug development and treatment?
ScholarIQopenalex
The OpenAlex for HIV/AIDS drug development and treatment is on the source record.
What are the most-cited papers on HIV/AIDS drug development and treatment?
ScholarIQmost cited works
Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
Ann C. Collier, Robert W. Coombs, David Schoenfeld, Roland L. Bassett, Joseph Timpone, Alice Baruch, Michelle Jones, Karen Facey, Caroline C. Whitacre, Vincent McAuliffe, Harvey M. Friedman, Thomas C. Merigan, Richard C. Reichman, Carol J. Hooper, Lawrence Corey
Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development
Sanjay R. Chemburkar, John F. Bauer, Kris C. Deming, Harry Spiwek, Ketan Patel, John B. Morris, Rodger F. Henry, Stephen G. Spanton, Walter Dziki, W.W. Porter, J. Quick, Phil J. Bauer, John Donaubauer, B. A. Narayanan, Mauro Soldani, Dave Riley, Kathyrn McFarland
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
Kenneth A. Freedberg, Elena Losina, Milton C. Weinstein, A. David Paltiel, Calvin Cohen, George R. Seage, Donald E. Craven, Hong Zhang, April D. Kimmel, Sue J. Goldie
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
John D. Baxter, Douglas L. Mayers, Deborah Wentworth, James D. Neaton, Marie L. Hoover, Mark A. Winters, Sharon Mannheimer, Melanie Thompson, Donald I. Abrams, Barbara Brizz, John P. A. Ioannidis, Thomas C. Merigan
Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease Inhibitors
Frederick Hecht, Robert M. Grant, Christos J. Petropoulos, Beth Dillon, Margaret A. Chesney, Huan Tian, Nicholas S. Hellmann, Nirmala I. Bandrapalli, Laura Digilio, Bernard M. Branson, James O. Kahn
Where is HIV/AIDS drug development and treatment research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on HIV/AIDS drug development and treatment is open access?
ScholarIQopen access share
67%OPEN ACCESS